Propeller Health

Congratulations to our SVP of Marketing, VJ Bala, for being named to the 2024 #AX100 alongside industry leaders transforming customer experiences across the world! "Differentiated experiences impact loyalty more than products alone and are crucial in industries like healthcare where digital adoption is challenging," shared VJ. We couldn't agree more. #CX 

Excited to share that our SVP of Marketing, VJ Bala, is a finalist for the OnConferences Top Marketer Award for the second year in a row! This nomination highlights the remarkable accomplishments he and his team have made in helping uplift the lives of people living with chronic disease. If you resonate with our shared vision, your vote would mean a lot. Let's continue to champion thought leadership and innovation in healthcare together! You can vote using this link: https://lnkd.in/eUuCiZaq #OnConIconAwards #OnConferences

Congratulations to all of the new and returning members of the Digital Therapeutics Alliance Board of Directors! We're proud to have Susa Monacelli join the DTA Board alongside: Everett Crosland at Clara Care Inc Aaron Gani at RealizedCare Anand Iyer at Welldoc Jared Josleyn, J.D. at Sanofi Danny Kim, PharmD at WELT corp Hannes Klöpper at HelloBetter Eddie Martucci at Akili Owen McCarthy at MedRhythms, Inc. Andy Molnar at Digital Therapeutics Alliance Debra Reisenthel at Freespira We look forward to all of the progress we know they will make in 2024!

“If you can't breathe, a lot of other problems are much more difficult to overcome," Susa Monacelli shares with #HITshow host, Dennis Dailey. At Propeller, we're proud of the solutions we've developed for patients and caregivers, the value we've created for providers, health systems, payers and life sciences, and our commitment to uplifting every person living with a chronic disease.

An estimated 80% of health outcomes are linked to social determinants of health. For payers and value-based care organizations, this means one thing: To achieve better outcomes — and improve quality measures — advancing health equity needs to be a top priority. Enter: digital health. With the right digital solutions, clinical teams can: • Better understand health disparities in their patient populations • Develop targeted interventions that empower patients and reduce barriers to care • Drive better outcomes among underserved patient populations • Improve quality measures focusing on health equity Learn more about the critical role digital health plays in helping organizations reach their health equity goals in our latest white paper: https://lnkd.in/gY-J4ntD

The adage “prevention is better than cure” is becoming more relevant than ever in healthcare, especially given the steady push toward value-based care. Here’s a glimpse into what healthcare’s near future may hold — and how it will impact health systems, payers, and life sciences companies alike: https://lnkd.in/gBRUnqT2

The problem: 1 in 5 Medicare patients are readmitted to the hospital within 30 days of discharge. The solution: Digital health insights that help clinical teams identify patients at risk of readmission so they can intervene before patients end up back in the hospital — enabling clinical teams to reduce readmission rates among Medicare patients and improve quality measures. Read more in our latest white paper: https://lnkd.in/gY-J4ntD

New research shows that ML models are highly accurate at predicting rescue medication use, a potential signal for impending exacerbations, when utilizing patient medication use data — collected by digital health platforms like Propeller — in conjunction with other inputs including air pollutant and weather data. This finding highlights the promise of digital health platforms in revolutionizing the management of high-cost chronic diseases by enabling the identification, prediction, and ultimately, prevention of exacerbations. Learn more: https://lnkd.in/gUrc24mY

From the rise of direct-to-consumer models to the increased focus on prevention over treatment, the 2024 healthcare landscape promises to be as exciting as it is challenging. Here’s a glimpse into what healthcare’s near future may hold — and how it will impact health systems, payers, and life sciences companies alike: https://lnkd.in/gBRUnqT2

Did you know Chronic Obstructive Pulmonary Disease (COPD) is the world's 3rd leading cause of death? Today, 480 million people live with COPD – and according to a new study published in the Journal of the American Medical Association (JAMA) Network Open, that number is expected to reach approximately 600 million in 2050.   “These numbers are a clear warning that we need to inspire immediate action across industries and geographies to lower the risk factors for COPD while also increasing awareness of the symptoms of this deadly disease.” - Carlos M. Nunez, M.D., Chief Medical Officer at ResMed  Although COPD is progressive, it is treatable, and proper management and early intervention can provide symptom control, improved quality of life, and reduced risk of associated health problems. ResMed is committed to helping people living with #COPD through our evidence-based products and solutions.   Learn more about the increased regional and global burden of COPD by 2050 in new studies published in JAMA Network Open: https://lnkd.in/g2v3eAE6